Novo Nordisk shares rise as Wegovy shows heart benefits beyond weight loss
By Maggie Fick LONDON (Reuters) -Novo Nordisk shares rose 3% on Monday as the market reacted to data the drugmaker
2023-11-13 19:56
China’s Carbon Emissions to Drop Next Year on Clean Energy Boom
A surge in clean power generation will reduce carbon emissions in China next year and could put the
2023-11-13 09:47
Wegovy's heart benefits due to more than weight loss, Novo says
By Patrick Wingrove PHILADELPHIA (Reuters) -Novo Nordisk on Saturday said the heart protective benefits of its wildly popular Wegovy obesity
2023-11-12 22:48
Weight-loss drug maker Novo Nordisk invests $6 billion to boost output
COPENHAGEN Novo Nordisk said on Friday it will invest more than 42 billion crowns ($6 billion) in its
2023-11-10 17:23
China 2024 Budget Deficit Seen Above 3.5% In Break With Past
China will likely set its headline deficit at 3.5% of gross domestic product or higher next year, according
2023-11-10 15:57
UnitedHealth unit to add eight insulin products to its reimbursement list
(Reuters) -UnitedHealth's pharmacy benefit manager unit said on Thursday it was adding eight insulin products to its reimbursement list that
2023-11-10 01:29
AstraZeneca ups profit outlook on strong cancer drugs demand
By Maggie Fick and Eva Mathews LONDON (Reuters) -AstraZeneca raised its annual earnings forecast on Thursday, helped by strong demand
2023-11-09 16:26
Zimmer Biomet beats quarterly profit estimates on knee procedure strength
Zimmer Biomet Holdings Inc on Tuesday beat Wall Street estimates for third-quarter profit, as a rebound in knee
2023-11-07 20:59
Novo Nordisk flags continued restrictions on Wegovy supplies
COPENHAGEN (Reuters) -Novo Nordisk on Thursday reported record sales and operating profits for the third quarter but flagged continued restrictions
2023-11-02 14:48
Former Google CEO Eric Schmidt Bets AI Will Shake Up Scientific Research
Eric Schmidt is funding a nonprofit that’s focused on building an artificial intelligence-powered assistant for the laboratory, with
2023-11-01 19:59
U.S. FDA approves Amgen's biosimilar version of J&J's psoriasis drug
The U.S. Food and Drug Administration on Tuesday approved Amgen's biosimilar version of Johnson & Johnson's blockbuster psoriasis
2023-11-01 07:30
Pfizer swings to loss as COVID product demand slump sparks charges
(Reuters) -Pfizer on Tuesday reported its first quarterly loss since 2019, as demand fell for its COVID products and it
2023-10-31 19:53